Pharmaceutical Logistics Market - Global Outlook & Forecast 2022-2027

Pharmaceutical Logistics Market - Global Outlook & Forecast 2022-2027

The global pharmaceutical logistics market is expected to grow at a CAGR of 7.96% during 2022-2027.

MARKET OVERVIEW

Technological advancements are disrupting the logistics providers to improve the healthcare business model ecosystem, including pharmaceuticals. Further, increased usage of logistics optimization tools, AI, IoT, and intelligent logistics platforms are likely to contribute to the future growth of the pharmaceutical logistics market.

Pharmaceutical logistics deals with manufacturing, processing, shipping materials, and resources and activities related to handling manufactured goods by their customers. Logistics companies play a crucial role in the functioning of any pharmaceutical company. The growing adoption of water-based pharmaceutical logistics is one of the significant driving factors in the pharmaceutical logistics market. Pharmaceutical logistics showed a healthy growth rate even before the COVID-19 pandemic. The sector is undergoing several changes as the geriatric population drives the need for new pharma solutions. However, the COVID-19 pandemic has created complexities in the global supply chain that has impacted all the modes of freight transportation, from air to rail cargo, that may take months or years to get back to normal.

TRENDING FACTORS

Clinical research has recently become more globalized, with many of these studies being conducted globally and a significant increase in clinical trials in developing countries. The focus of clinical trial researchers is now shifting from developed markets of Japan, Australia, South Korea, and Singapore towards emerging economies like Thailand, China, the Philippines, and Vietnam.

Major companies are striving to offer cloud-based supply chain services and secured supply chain functions as it helps pharmaceutical manufacturers safeguard the validity of the drugs. These solutions are expected to prevent the production and distribution of counterfeit drugs. According to DB Schenker, a subsidiary of DB Group, to increase transport density and reliability, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential in the pharmaceutical logistics market. Also, in 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group to provide industry-leading digital supply chain IT solutions for cell and gene therapies. Also, the recent emergence of cell and gene therapy is expected to create lucrative opportunities for the pharmaceutical logistics market.

Driving Factors Of The Global Pharmaceutical Logistics Market:

  • Need for secure cold-chain solutions and increased monitoring
  • Evolving storage and transportation needs
  • Rising branded, generic, and OTC drugs
SEGMENTATION INSIGHTS

INSIGHTS BY THERAPY AREA
  • In therapy area segmentation, the communicable diseases segment dominated the global pharmaceutical logistics market with a share of 19.96% owing to the emergence of the COVID-19 pandemic that upsurged the communicable disease cases. According to the latest European Centre for Disease Prevention and Control (ECDC) report, tuberculosis remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern that is made the communicable diseases dominant in the last few years. In 2019, communicable diseases ranked third with the highest number of cases, while the emergence of the COVID-19 pandemic dominated the segment in 2021. The upsurge in COVID-19 cases contributed to the highest share of communicable diseases, leading to increased demand for OTC medicines and vaccines.
  • The oncology segment accounted for the second-largest segment in the pharmaceutical logistics market with a revenue share of 15.17%, owing to growing cancer prevalence and demand for anti-tumor agents. It is also expected to grow at the highest CAGR of 14.02%. The current pharmaceuticals pipeline is disproportionately focused on cancer.
  • The world is expecting more pandemics in the future, particularly with monkeypox spreading in more than 60 countries which are expected to drive the demand for new medications and more clinical trials, thus boosting the demand for logistics during clinical trials and distributing products.
Segmentation by Therapy Area
  • Communicable Diseases
  • Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Neurological Disorders
  • Pain Management
  • Respiratory Diseases
  • Others
INSIGHTS BY ORIGIN
  • Under origin segmentation, branded drugs accounted for the highest revenue share in the global pharmaceutical logistics market. This is mainly due to their high preference and the high cost of branded drugs, which makes up the high revenue share of pharmaceutical logistics for branded drugs. According to the Association for Accessible Medicines, US Generic & Biosimilar Medicines Savings Report and National Sales Perspectives, in December 2020, branded drugs spending was around 80% of the share from 2018-2020. However, the generic drugs segment is expected to grow at the highest CAGR of 72.25% during the forecast period.
Segmentation by Origin
  • Branded
  • Generic
  • OTC
INSIGHTS BY PRODUCT
  • Under product segmentation, small molecule drugs dominate the global pharmaceutical logistics market with a revenue share of 63.02% in 2021 due to increasing demand and its cost-effectiveness, ease of administration, and easy dosing. The demand for small-molecule drugs remains high, with figures showing that 97% of marketed drugs are classified as small molecules. However, biologics lead among the top-selling products and new sales generators projected for 2022, whereas small molecules continue to lead in new drug approvals. According to US FDA’s Center for Drug Evaluation and Research, of the 50 new molecular entities approved by the US FDA’s Center for Drug Evaluation and Research in 2021, 36 (72%) were small molecules, and 14(28%) were biologics.
Segmentation by Product
  • Small Molecule Drugs
  • Biologics
INSIGHTS BY FUNCTION
  • As transportation is a crucial part of the logistics chain, thus it accounts for the highest revenue share of 71.66% in the pharmaceutical logistics market in 2021 and continues to grow with the highest CAGR of 8.20% during the forecast period. The demand for temperature-controlled transportation is also rising to maintain the quality of the products. Road transportation dominates the transportation segment with a revenue share of 66.38% in 2021, whereas the water and air transportation segments accounted for 21.21% and 12.41%, respectively, in the same year. The highest share of road transportation can be attributed to its low cost in terms of workforce and operation. In January 2021, more than 58% of US-Canada cross-border freight was moved by trucks, followed by rail with more than 16% of cross-border freight.
  • However, in 2020, European land transport declined because of the COVID-19 pandemic. Between April and August 2020, after decreased prices and falling demand, prices grew exponentially to the previous year’s level from October 2020, and the demand increased significantly. As the air rates are higher than water and road, thus the demand for logistics via air is lowest.
  • Air freight is 78% more expensive than ocean freight, leading the pack with 80% of all temperature excursions for pharmaceutical products transportation. In comparison, ocean transportation has a mere 1% temperature excursion rate, while road transport is a little higher, with 18% of all the excursions. There is still a lot of work for the air cargo supply chain to come up to speed for the growing global trade in pharmaceutical products. Despite that, the global pharmaceutical logistics market by air is growing at the fastest CAGR of 9.16% during the forecast period.
Segmentation by Function
  • Transportation
  • Warehousing
  • Others
GEOGRAPHY INSIGHTS

 North America region accounts for the highest revenue share of 38.70% in the global pharmaceutical logistics market in 2021 and holds the presence of most pharmaceutical suppliers. The US is the leading country worldwide with the highest share of pharmaceuticals. About five of the ten top pharmaceutical companies in 2020 were from the US. In the US, branded drugs accounted for around 83.9% of spending. In 2020, about 8.1% of worldwide drug and medicine shipments originated from North America.

 North America and Europe have accounted for about 80% of monoclonal antibodies market share alone; thus, the growing demand for biologics, i.e., vaccines and monoclonal antibodies, and increasing investments in R&D are the major driving factors for the pharmaceutical logistics market. Europe is the number one exporter of pharmaceutical drugs. The pharmaceutical logistics demand in Europe is driven by the growing demand for biologics such as vaccines, propelled by the COVID-19 pandemic and growing investments by leading pharmaceutical firms. In 2019, pharmaceutical industry sales in the country increased by 5.7%, reaching about USD 52.1 billion. More than 500 pharmaceutical companies are in Germany. Small and mid-size enterprises (SMEs) constitute the backbone of the economic sector, with around 90% of drug manufacturers. In 2018, Germany generated a production value of USD 42.1 billion, making it the leading pharmaceutical manufacturing country in Europe.

 The pharmaceutical logistics market in APAC was valued at USD 20.79 billion in 2021. Asia Pacific is the largest manufacturing region and provider of generic drugs, vaccines, OTC drugs, biosimilars, custom research manufacturing, and active pharmaceutical ingredients; many countries are importing pharmaceuticals from this region. Hence, the growing demand for these pharmaceutical products is the major driving factor for transportation and warehousing activities in the region. India has the highest share of about 20% of the global supply volume. Moreover, it contributes to around 60% of global vaccines. India majorly exports biologics, which contribute to about 75% of the total pharmaceutical exports out of India. In addition, Latin America, the Middle East & Africa, and the APAC region are the major emerging markets for pharmaceutical logistics market growth. Factors such as rapid population growth, steady increase in the elderly population, and increased prevalence of chronic, non-communicable diseases are the major driving factors in these regions for growth in the pharmaceutical logistics market.

Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • Italy
  • Spain
  • France
  • UK
  • APAC
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa
VENDOR LANDSCAPE

AmerisourceBergen, CEVA Logistics, Deutsch Post DHL, FedEx, Kuehne + Nagel, DB Schenker, and UPS are the key vendors in the pharmaceutical logistics market. These companies have a broad geographical footprint, a strong focus on innovation in logistics, and a diversified service portfolio. Upcoming new advanced technologies and increased demand for personalized medicines are providing lucrative opportunities for stakeholders to take the companies to the next level. Technologies such as data mining, mobile cloud, time analytics, and blockchain are expected to create better app interfaces and cloud infrastructure, which is expected to provide better growth opportunities in the post-pandemic pharmaceutical logistics market.

In addition to technological advances, companies invest in inorganic growth methods such as acquisitions. For instance, on June 2, 2021, the leading company, AmerisourceBergen, completed the acquisition of most of Walgreens Boots Alliance’s Alliance Healthcare businesses for USD 6.27 billion cash which will help the company expand its reach and solutions in pharmaceutical distribution. Similarly, In August 2021, the leading company Deutsche Post DHL Group, signed an agreement to acquire 100% of J.F. Hillebrand Group and its subsidiaries.

Key Vendors
  • AmerisourceBergen
  • CEVA Logistics
  • DB Group
  • Deutsche Post DHL
  • FedEx
  • Kuehne + Nagel
  • United Parcel Service
Other Prominent Vendors
  • ABS Logistics
  • AWL India
  • Alloga
  • BOLLORÉ LOGISTICS
  • Cardinal Health
  • C.H. Robinson
  • Cold Chain Technologies
  • CRYOPDP
  • DPD
  • DSV
  • Farmasoft
  • Jeena & Company
  • Lufthansa Cargo
  • Maersk
  • Medline
  • Nippon Express
  • Noatum Logistics
  • Owens & Minor
  • Oximio
  • Pharma Logistics
  • PHOENIX Group
  • Parexel International
  • SEKO Logistics
  • Singapore Post
  • SINOTRANS
  • XPO Logistics
  • Yourway
  • YUSEN LOGISTICS
KEY QUESTIONS ANSWERED

1. How big is the pharmaceutical logistics market?

2. What is the pharmaceutical logistics market growth?

3. What are the trends in the global pharmaceutical logistics market?

4. Which region holds the largest pharmaceutical logistics market share globally?

5. Which are the leading companies in the global pharmaceutical logistics market?

6. What is the leading product in the pharmaceutical logistics market?


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.4 MARKET SEGMENTATION
4.4.1 MARKET BY PRODUCT
4.4.2 MARKET BY POWER SOURCE
4.4.3 MARKET BY APPLICATOR TYPE
4.4.4 MARKET BY END-USER
4.4.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1.1 MARKET OVERVIEW
7.1.2 MARKET TRENDS
7.1.3 MARKET OPPORTUNITIES
7.1.4 MARKET DRIVERS
7.1.5 MARKET CHALLENGES
7.1.6 SEGMENT REVIEW
7.1.7 COMPANY & STRATEGIES
7.1.8 COMPANY PROFILES
8 INTRODUCTION
8.1 OVERVIEW
8.2 PAINT RECYCLING
8.3 VALUE CHAIN
8.3.1 MATERIAL SUPPLIERS
8.3.2 MANUFACTURERS
8.3.3 DISTRIBUTORS
8.3.4 APPLICATION
8.4 FREQUENTLY ASKED QUESTION (FAQ)
8.4.1 CAN FLAMMABLE OR COMBUSTIBLE MATERIALS BE USED WITH PAINT SPRAYERS?
8.4.2 IS OPERATING A PAINT SPRAYER EASY?
8.4.3 WHAT KIND OF PAINTS CAN BE USED IN PAINT SPRAYERS?
8.4.4 WHAT IS THE SUITABLE TYPE OF PAINT SPRAYER FOR RESIDENTIAL USE?
8.4.5 IS IT WORTH GETTING A PAINT SPRAYER?
8.4.6 WHAT IS THE BEST PRESSURE FOR SPRAY PAINTING?
8.4.7 HOW RUNNY SHOULD THE PAINT BE FOR A SPRAY GUN?
8.4.8 DOES SPRAYING PAINT REQUIRES TWO COATS?
8.5 AUTOMOTIVE INDUSTRY
8.6 CONSTRUCTION INSIGHTS
8.6.1 RESIDENTIAL CONSTRUCTION
8.6.2 COMMERCIAL CONSTRUCTION
8.6.3 PUBLIC INFRASTRUCTURAL CONSTRUCTION
9 MARKET OPPORTUNITIES & TRENDS
9.1 EFFICIENT & SUSTAINABLE SPRAY PAINTING
9.2 TECHNOLOGICAL ADVANCES
9.3 HOME IMPROVEMENT PROJECTS
10 MARKET GROWTH ENABLERS
10.1 GROWTH OF AUTOMOTIVE INDUSTRY
10.2 GROWTH IN DIY ACTIVITIES
10.3 ADVANCES IN LI-ION BATTERIES
10.4 GROWING CONSTRUCTION INDUSTRY
11 MARKET RESTRAINTS
11.1 FLUCTUATIONS IN RAW MATERIAL PRICES
11.2 COST & MAINTENANCE OF PAINT SPRAYERS
11.3 LOW-COST LABOR IN DEVELOPING ECONOMIES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 AIR
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 AIRLESS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 ELECTROSTATIC
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 OTHERS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
14 POWER SOURCE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 CORDED
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 CORDLESS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 APPLICATOR TYPE
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 MANUAL
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 AUTOMATIC
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 INDUSTRIAL & COMMERCIAL
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 RESIDENTIAL
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 PRODUCT
18.3.1 MARKET SIZE & FORECAST
18.4 POWER SOURCE
18.4.1 MARKET SIZE & FORECAST
18.5 APPLICATOR TYPE
18.5.1 MARKET SIZE & FORECAST
18.6 END-USER
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 CHINA: MARKET SIZE & FORECAST
18.7.2 JAPAN: MARKET SIZE & FORECAST
18.7.3 SOUTH KOREA: MARKET SIZE & FORECAST
18.7.4 INDIA: MARKET SIZE & FORECAST
18.7.5 AUSTRALIA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 PRODUCT
19.3.1 MARKET SIZE & FORECAST
19.4 POWER SOURCE
19.4.1 MARKET SIZE & FORECAST
19.5 APPLICATOR TYPE
19.5.1 MARKET SIZE & FORECAST
19.6 END-USER
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 GERMANY: MARKET SIZE & FORECAST
19.7.2 ITALY: MARKET SIZE & FORECAST
19.7.3 UK: MARKET SIZE & FORECAST
19.7.4 SPAIN: MARKET SIZE & FORECAST
19.7.5 FRANCE: MARKET SIZE & FORECAST
20 NORTH AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 PRODUCT
20.3.1 MARKET SIZE & FORECAST
20.4 POWER SOURCE
20.4.1 MARKET SIZE & FORECAST
20.5 APPLICATOR TYPE
20.5.1 MARKET SIZE & FORECAST
20.6 END-USER
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 US: MARKET SIZE & FORECAST
20.7.2 CANADA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 PRODUCT
21.3.1 MARKET SIZE & FORECAST
21.4 POWER SOURCE
21.4.1 MARKET SIZE & FORECAST
21.5 APPLICATOR TYPE
21.5.1 MARKET SIZE & FORECAST
21.6 END-USER
21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
21.7.1 MEXICO: MARKET SIZE & FORECAST
21.7.2 BRAZIL: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 PRODUCT
22.3.1 MARKET SIZE & FORECAST
22.4 POWER SOURCE
22.4.1 MARKET SIZE & FORECAST
22.5 APPLICATOR TYPE
22.5.1 MARKET SIZE & FORECAST
22.6 END-USER
22.6.1 MARKET SIZE & FORECAST
22.7 KEY COUNTRIES
22.7.1 SOUTH AFRICA: MARKET SIZE & FORECAST
22.7.2 GCC: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
24 COMPANY PROFILES
24.1 WAGNER
24.1.1 BUSINESS OVERVIEW
24.1.2 WAGNER SPRAYTECH
24.1.3 PRODUCT OFFERINGS
24.2 HOMERIGHT IN
24.2.1 PRODUCT OFFERINGS
24.2.2 TITAN TOOL
24.2.3 PRODUCT OFFERINGS
24.2.4 EARLEX
24.2.5 PRODUCT OFFERINGS
24.3 GRACO
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 LEMMER SPRAY SYSTEMS
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 SAMES
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 RONGPENG AIR TOOLS
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 BLASTECH
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 BUVICO SPRAYING EQUIPMENTS
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 VANDS ENGINEERING SOLUTION
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 MOD ENGINEERING
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 TECCPO
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 BATAVIA
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 NEU MASTER
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 ROBERT BOSCH
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 EXEL INDUSTRIES
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 LITHELI
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 YATTICH
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 WORKSITE
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 HYCHIKA
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 NOCRY
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 FUJI INDUSTRIAL SPRAY EQUIPMENT
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 PRODUCT
26.2 POWER SOURCE
26.3 APPLICATOR TYPE
26.4 END-USER
26.5 GEOGRAPHY
26.6 APAC
26.6.1 PRODUCT
26.6.2 POWER SOURCE
26.6.3 APPLICATOR TYPE
26.6.4 END-USER
26.7 EUROPE
26.7.1 PRODUCT
26.7.2 POWER SOURCE
26.7.3 APPLICATOR TYPE
26.7.4 END-USER
26.8 NORTH AMERICA
26.8.1 PRODUCT
26.8.2 POWER SOURCE
26.8.3 APPLICATOR TYPE
26.9 END-USER
26.9.1 END-USER
26.10 LATIN AMERICA
26.10.1 PRODUCT
26.10.2 POWER SOURCE
26.10.3 APPLICATOR TYPE
26.10.4 END-USER
26.11 MIDDLE EAST & AFRICA
26.11.1 PRODUCT
26.11.2 POWER SOURCE
26.11.3 APPLICATOR TYPE
26.11.4 END-USER
27 APPENDIX
27.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings